health

Tech

Google DeepMind unveils protein design system

Google DeepMind has unveiled an AI system called AlphaProteo that can design novel proteins that successfully bind to target molecules,…

Read More »
New Business

Li Ka-shing’s HutchMed sets up first drugs research facility in Hong Kong

HutchMed aims to establish a bigger presence in the city when the first wet laboratories at the much larger Hong…

Read More »
Tech

Chinese biotech sector is blowing hot as M&A and IPO deals surge amid Covid-19 pandemic

China’s biotechnology merger and acquisition (M&A) transactions have almost doubled this year, with interest perking up among investors amid a…

Read More »
Tech

Yifan Pharma’s unit, eyeing US$5.5 billion post-chemotherapy treatment market dominated by Amgen, considers IPO in 2021

Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…

Read More »
Tech

China’s largest e-cigarette brand Relx to study health effects of vaping amid regulatory crackdowns

The company unveiled a new bioscience laboratory on Thursday to study the health effects of vaping. The lab in Shenzhen…

Read More »
Tech

Gene editing: Chinese scientists bring safer pig-to-human organ transplants one step closer to reality

A team led by Chinese researchers say they have succeeding in producing genetically modified pigs with cells that are more…

Read More »
Tech

GeneHarbor plans Hong Kong IPO to fund new medicinal products, widen anti-ageing supplements line

The dietary supplement producer, established in 2004, spent 2 billion yuan (US$294 million) to build a factory this year in…

Read More »
Tech

Inside China Tech: Is that TikTok deal happening or not?

Beijing-based ByteDance, which has been criticised in its home market for entering negotiations with American companies soon after US President…

Read More »
Tech

Billionaire Li Ka-shing’s biotech unit hopes for new cancer drug approvals, expands sales army in China amid stock rally in London

Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to…

Read More »
Tech

Hong Kong scientist behind artificial ‘mini-hearts’ takes Novoheart closer to China with facilities to quicken drug discovery process

Novoheart Holdings, the inventor of artificial “mini-hearts” co-founded by a Hong Kong scientist, is expanding its research and manufacturing budget…

Read More »
Back to top button